Trials / Completed
CompletedNCT03853681
Study on the Response to Tetanus Vaccination of People Living With HIV
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 210 (actual)
- Sponsor
- Centre Hospitalier de Niort · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The response to primary tetanus immunization of HIV-infected children is lower than that of uninfected children. Response to tetanus toxoid (TT) booster doses in adults living with HIV who have received primary vaccination prior to infection is not known. Currently, it is recommended to have a TT booster for people living with HIV (PLHIV) every 10 years. In general population, this recall is made only at 25, 45 and 65 years, then every 10 years.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | additional blood sampling | additional blood sampling |
Timeline
- Start date
- 2019-03-11
- Primary completion
- 2019-09-11
- Completion
- 2020-02-24
- First posted
- 2019-02-26
- Last updated
- 2020-10-05
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT03853681. Inclusion in this directory is not an endorsement.